Search

Search Constraints

You searched for: Author/Creator Gutierrez, Julio A.

Search Results

5. Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials. Issue 11 (8th September 2021)

8. Short‐duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial. Issue 2 (19th December 2016)

9. Simeprevir, daclatasvir, and sofosbuvir for hepatitis C virus‐infected patients: Long‐term follow‐up results from the open‐label, Phase II IMPACT study. Issue 2 (22nd February 2020)